Laurus Labs Q2 Outcomes: Laurus Labs reported a major improve in income and internet revenue for the second quarter of fiscal yr 2026.
The corporate’s income rose by 35% year-on-year to ₹1,653 crore, whereas internet revenue surged by 875% to ₹195 crore, in keeping with its earnings launch. Consolidated income for the half-year ended September 30, 2025, reached ₹3,223 crore, marking a 33% development in comparison with the identical interval final yr.
The EBITDA for the quarter was ₹429 crore, reflecting a 136% improve, with margins increasing to 26.0%. For the half-year, EBITDA stood at ₹818 crore, representing a 132% development, with margins at 25.4%. The corporate reported a gross margin enchancment of over 4.5 proportion factors to 59.6%, pushed by a beneficial enterprise combine and operational enhancements.
Divisional Income Efficiency
The corporate’s CDMO enterprise noticed a income improve to ₹518 crore in Q2, a 53% rise year-on-year, and ₹1,040 crore for the half-year, up 74%.
The small molecules section inside CDMO reported Q2 revenues of ₹471 crore, a 58% improve year-on-year. The generics enterprise additionally carried out properly, with revenues rising to ₹1,135 crore in Q2, a 28% improve year-on-year, and ₹2,183 crore for the half-year, a 20% rise.
Laurus Labs’ R&D expenditure for the half-year was ₹137 crore, accounting for 4.3% of revenues. The corporate continued to put money into increasing its manufacturing capabilities, with CAPEX at 15% of gross sales. The corporate additionally made a strategic funding of US$2 million in Aarvik Therapeutics to entry novel Antibody-drug conjugates (ADC) expertise.
Dr Satyanarayana Chava, Founder & CEO, acknowledged, “We proceed to take care of management place in ARVs and make encouraging progress in delivering essential scientific and industrial applications.”
V V Ravi Kumar, Govt Director & CFO, commented, “Our sturdy Q2 efficiency was in step with expectations. We now have achieved revenues of ₹1,653 crore, representing 35% development and EBITDA of ₹429 crore, representing 136% development.”
The corporate declared an interim dividend of ₹0.80 per share.
Disclaimer: This text was generated utilizing AI instruments and has undergone editorial assessment for readability and coherence.
